A multicenter randomized controlled trial on the efficacy and safety of the direct oral anticoagulant edoxaban in anticoagulation therapy after bioprosthetic valve replacement
Latest Information Update: 28 Jan 2025
Price :
$35 *
At a glance
- Drugs Edoxaban (Primary) ; Warfarin (Primary)
- Indications Embolism; Stroke
- Focus Therapeutic Use
- Acronyms ENBALV
- 28 Jan 2025 New trial record